首页> 外文期刊>General Pharmacology >Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain.
【24h】

Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain.

机译:NRA0045,NRA0160和NRA0215对大鼠大脑区域Fos样免疫反应的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

Pharmacological characteristics of NRA compounds, novel atypical antipsychotics, were compared with those of clozapine and haloperidol, in regard to modification of Fos-like immunoreactivity (FLI) in rats. (R)-(+)-2-Amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl] thiazole (NRA0045) and 2-carbamoyl-4-phenyl-5-[2-[4-(4-fluorobenzylidene) piperidin-1-yl] ethyl] thiazole (NRA0215) have a high affinity for dopamine D4 receptors, serotonin2A receptors, and the alpha1 adrenoceptor. 2-Carbamoyl-4-(4-fluorophenyl)-5-[2-[4-(3-fluorobenzylidene) piperidin-1-yl] ethyl] thiazole (NRA0160) has a selective and high affinity for dopamine D4 receptors. NRA0045 and clozapine (10 and 30 mg/kg, IP) produced significant increases in FLI in both the nucleus accumbens (N. Acc.) and the medial prefrontal cortex (mPFC) but not in the dorsolateral striatum (DLS). In contrast, NRA0160 and NRA0215 (10 and 30 mg/kg, IP) significantly increased FLI in the mPFC but not in the N. Acc. and the DLS. Haloperidol (0.1 and 1 mg/kg, IP) significantly produced FLI in the N. Acc., the DLS, and the mPFC. These data indicate that the antagonistic effects of dopamine D4 receptors may contribute, at least in part, to the actions of NRA0045, NRA0160, and NRA0215 in the mPFC.
机译:比较了NRA化合物(新型非典型抗精神病药)与氯氮平和氟哌啶醇在大鼠Fos样免疫反应性(FLI)修饰方面的药理特性。 (R)-(+)-2-氨基-4-(4-氟苯基)-5- [1- [4-(4-氟苯基)-4-氧丁基]吡咯烷-3-基]噻唑(NRA0045)和2 -氨基甲酰基-4-苯基-5- [2- [4-(4-氟苄叉基)哌啶-1-基]乙基]噻唑(NRA0215)对多巴胺D4受体,5-羟色胺2A受体和α1肾上腺素受体具有高亲和力。 2-氨基甲酰基-4-(4-氟苯基)-5- [2- [4-(3-氟亚苄基)哌啶-1-基]乙基]噻唑(NRA0160)对多巴胺D4受体具有选择性和高亲和力。 NRA0045和氯氮平(10和30 mg / kg,IP)在伏隔核(N. Acc。)和内侧前额叶皮层(mPFC)中的FLI均显着增加,而在背外侧纹状体(DLS)中则没有。相反,NRA0160和NRA0215(10和30 mg / kg,IP)在mPFC中显着增加FLI,但在N. Acc。中没有。和DLS。氟哌啶醇(0.1和1 mg / kg,IP)在N. Acc。,DLS和mPFC中显着产生FLI。这些数据表明,多巴胺D4受体的拮抗作用可能至少部分有助于mPFC中NRA0045,NRA0160和NRA0215的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号